Clinical TrialsSearch results
Number of results: 227
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07
Other
- Clinical examination about immunoadsorption therapy for dilated cardiomyopathy
- dilated cardiomyopathy
- Department of Cardiology, Kitasato Institute Hospital
- 2007-03-01
Other
- Japanese Diastolic Heart Failure Study
- Diastolic heart failure
- J-DHF Study group
- 2006-02-01
Other
- Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT)
- Diabetic peripheral neuropathy
- The Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT) Study Group
- 2007-02-20
Other
- Epalrestat effect on diabetic neuropathy in primary care setting
- diabetic neuropathy
- Ishikawa Internal Medicine Association
- 2009-01-28
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Other
- Randomized multi-institutional study for effectiveness of intervention on life style in obese patients with fasting hyperglycemia or abnormal glucose tolerance test.
- Diabetes mellitus (Pre-diabetes )
- All Japan Federation of Social Insurance Associations
- 2009-05-12
Other
- Japan Diabetes Complications Study
- diabetes mellitus
- Japan Diabetes Complications Study(JDCS) group
- 2005-12-01
Other
- A multicentre study on clinical usefulness of urinary trypsinogen-2 for early diagnosis of acute pancreatitis.
- Definite or possible acute pancreatitis.
- Division of Gastroenterology, Tohoku University Graduate School of Medicine
- 2009-01-07
Completed
- Phase III clinical trial of favipiravir in early-onset COVID-19 patients with severe risk factors
- COVID-19 patients with risk factors of progression to severe disease onset within 72 hours prior to
- Sakurai Tsutomu
- 2021-04-14